Delivery Order SPE2DB20D1004-SPE2DB23FG2M9
Award Date
7/20/23
Potential Completion Date
7/21/23
Potential Value
$2.3K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Cencora, Inc.
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $5,227.06, is a Firm Fixed Price Delivery Order for the pharmaceutical product OPZELURA 1.5% CREAM 60GM. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This federal contract award, valued at $15,092.33, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is a delivery order for the pharmaceutical product OPZELURA 1.5% CREAM 60GM. The contract has an ultimate completion date of December 28, 2023 and is a firm fixed-price delivery order, with no set-aside designation. Amerisourcebergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider that...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,806.21, is for the delivery of OPZELURA 1.5% CREAM 60GM, a pharmaceutical product, to support federal healthcare programs. The contract is a delivery order under an Indefinite Delivery Contract (IDC) held by Amerisourcebergen's parent company, Cencora, Inc., with the DLA Troop Support Medical....
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The contract has a ceiling value of $2,832.19 and is a Delivery Order (DO) type, with a Firm Fixed Price (FFP) pricing structure. The award is for the supply of OPZELURA 1.5% CREAM 60GM, a pharmaceutical product. The contract has a period of performance through February 9, 2024 and was awarded on February 8, 2024. This award is not...
This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a Delivery Order valued at $7,460.75 for the supply of the pharmaceutical product OPZELURA 1.5% Cream. The contract was awarded by the Defense Logistics Agency (DLA), a defense agency, and has an ultimate completion date of September 20, 2022. This award is not associated with a set-aside designation, indicating open competition. Amerisourcebergen Drug Corp is a major pharmaceutical distributor that...
This federal contract award, valued at $6,179.13, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of OPZELURA 1.5% CREAM 60GM, a pharmaceutical product. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary...
This federal contract award, valued at $5,422.11, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a pharmaceutical distribution company. The award is a delivery order under an existing Indefinite Delivery Contract (IDC) held by Amerisourcebergen's parent company, Cencora, Inc., with the DLA Troop Support Medical. The contract is for the delivery of OPZELURA 1.5% CREAM 60GM, a pharmaceutical product, to support military healthcare programs. The award does not have...
This federal contract award, valued at $4,557.55, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is a delivery order for the supply of OPZELURA 1.5% cream, a pharmaceutical product, to support military healthcare programs. The contract has an ultimate completion date of December 24, 2024, and is structured as a firm fixed-price agreement. The award is not associated with a set-aside designation, indicating open...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The $2,455.99 fixed-price delivery order is for the pharmaceutical product OPZELURA 1.5% Cream, 60 gm. The contract has an ultimate completion date of May 3, 2024. AmerisourceBergen, a major pharmaceutical distributor, holds two significant Indefinite Delivery Contracts (IDCs) with the DLA and the Department of Justice Federal Bureau of...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $6,086.16 firm fixed-price delivery order is for OPZELURA 1.5% cream, a medical product, with a period of performance through November 7, 2024. The contract does not have a set-aside designation, indicating open competition. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with...